InvestorsHub Logo
Followers 229
Posts 21458
Boards Moderated 2
Alias Born 08/03/2006

Re: ChrisIT post# 14910

Friday, 10/14/2016 8:15:34 AM

Friday, October 14, 2016 8:15:34 AM

Post# of 15766
The payment has already been addressed...

•The Company will make the $10 million prepayment on its debt facility triggered by the recently announced results of its Phase 3 study of vepoloxamer in early October 2016. After that prepayment, the principal amount of the Company's debt will be approximately $3.5 million, which is scheduled to be repaid in equal monthly installments of principal and interest through January 1, 2019.

http://masttherapeutics.com/investors/news/?releaseid=2205921

"Perfection is not attainable, but if we chase perfection we can catch
excellence." Vince Lombardi
Do your research! Play the TA. All posts are my opinion.